Syneron Bio Announces Completion of $150 Million Series B Financing

B BEIJING, April 3, 2026 /PRNewswire/ — Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series…
posteditor
posteditor
Articles: 16137

Other News